+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Intracoronary adenovirus-mediated delivery and overexpression of the beta(2)-adrenergic receptor in the heart : prospects for molecular ventricular assistance



Intracoronary adenovirus-mediated delivery and overexpression of the beta(2)-adrenergic receptor in the heart : prospects for molecular ventricular assistance



Circulation 101(4): 408-414



Background-Genetic modulation of ventricular function may offer a novel therapeutic strategy for patients with congestive heart failure. Myocardial overexpression of beta2-adrenergic receptors (beta2ARs) has been shown to enhance contractility in transgenic mice and reverse signaling abnormalities found in failing cardiomyocytes in culture. In this study, we sought to determine the feasibility and in vivo consequences of delivering an adenovirus containing the human beta2AR cDNA to ventricular myocardium via catheter-mediated subselective intracoronary delivery. Methods and Results-Rabbits underwent percutaneous subselective catheterization of either the left or right coronary artery and infusion of adenoviral vectors containing either a marker transgene (Adeno-betaGal) or the beta2AR (Adeno-beta2AR). Ventricular function was assessed before catheterization and 3 to 6 days after gene delivery. Both left circumflex- and right coronary artery-mediated delivery of Adeno-beta2AR resulted in apprxeq10-fold overexpression in a chamber-specific manner. Delivery of Adeno-betaGal did not alter in vivo left ventricular (LV) systolic function, whereas overexpression of beta2ARs in the LV improved global LV contractility, as measured by dP/dtmax, at baseline and in response to isoproterenol at both 3 and 6 days after gene delivery. Conclusions-Percutaneous adenovirus-mediated intracoronary delivery of a potentially therapeutic transgene is feasible, and acute global LV function can be enhanced by LV-specific overexpression of the beta2AR. Thus, genetic modulation to enhance the function of the heart may represent a novel therapeutic strategy for congestive heart failure and can be viewed as molecular ventricular assistance.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 010873608

Download citation: RISBibTeXText

PMID: 10653833


Related references

Intracoronary Adenovirus-Mediated Delivery and Overexpression of the 2-Adrenergic Receptor in the Heart : Prospects for Molecular Ventricular Assistance. Circulation 101(4): 408-414, 2000

In vivo intracoronary delivery and expression of a betaARK inhibitor to the failing heart Prospects for molecular ventricular assistance. Circulation 100(18 Suppl. ): I 481, 1999

Overexpression of the beta-2 adrenergic receptor in the rat heart through adenovirus mediated gene transfer. Journal of Cellular Biochemistry Suppl. 0(21A): 382, 1995

Global myocardial overexpression of beta2-adrenergic receptors via intracoronary adenovirus delivery enhances in vivo contractility. Circulation 98(17 Suppl. ): I737, 1998

Adenoviral mediated overexpression of human beta-2 adrenergic receptor after direct delivery into canine myocardium. Journal of the American College of Cardiology 27(2 Suppl. A): 289A, 1996

Transgenic mice with cardiac overexpression of alpha1B-adrenergic receptors. In vivo alpha1-adrenergic receptor-mediated regulation of beta-adrenergic signaling. Journal of Biological Chemistry 272(34): 21253-9, 1997

Targeted inhibition of beta-adrenergic receptor kinase-1-associated phosphoinositide-3 kinase activity preserves beta-adrenergic receptor signaling and prolongs survival in heart failure induced by calsequestrin overexpression. Journal of the American College of Cardiology 45(11): 1862-1870, 2005

In vivo ventricular gene delivery of a beta-adrenergic receptor kinase inhibitor to the failing heart reverses cardiac dysfunction. Circulation 103(9): 1311-1316, 2001

Enhancement of cardiac function after adenoviral-mediated in vivo intracoronary beta2-adrenergic receptor gene delivery. Journal of Clinical Investigation 104(1): 21-29, 1999

Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down- regulation in heart failure. Circulation Research 59(3): 297-309, 1986

Beta 1 and beta 2 adrenergic receptor subpopulations in nonfailing and failing human ventricular myocardium coupling of both receptor subtypes to muscle contraction and selective beta 1 receptor down regulation in heart failure. Circulation Research 59(3): 297-309, 1986

Analysis of beta-adrenergic receptor mRNA levels in human ventricular biopsy specimens by quantitative polymerase chain reactions: Progressive reduction of beta-1-adrenergic receptor mRNA in heart failure. Journal of the American College of Cardiology 27(1): 146-154, 1996

Paroxysmal beta-adrenergic receptor-mediated alterations in ventricular repolarization at rapid heart rates during inhibition of delayed rectifier currents. Journal of Cardiovascular Pharmacology 54(3): 253-262, 2009

The effect of adrenergic receptor antagonist on cocaine-induced ventricular fibrillation: Alpha but not beta adrenergic receptor antagonists prevent malignant arrhythmias independent of heart rate. Journal of Pharmacology and Experimental Therapeutics 269(1): 409-416, 1994

Inhibiting scar formation in rat wounds by adenovirus-mediated overexpression of truncated TGF-beta receptor II. Plastic and Reconstructive Surgery 115(3): 860-870, 2005